Amelioration of liver fibrosis with autologous macrophages induced by IL-34-based condition
Abstract Background For the treatment of liver fibrosis, several novel cell therapies have been proposed. Autologous macrophage therapy has been reported as one of the promising treatments. So far, most studies have used colony-stimulating factor 1 (CSF-1) to induce the differentiation of macrophage...
Saved in:
Main Authors: | Yuichi Igarashi, Haruka Wada, Masato Muto, Ryohei Sone, Yoshinori Hasegawa, Ken-ichiro Seino |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Inflammation and Regeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41232-025-00364-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Inflammatory Cytokine Secretion by Human Alveolar Macrophages
by: J. E. Losa García, et al.
Published: (1999-01-01) -
The role of the interleukin family in liver fibrosis
by: Zixin Zhang, et al.
Published: (2025-02-01) -
Myofibroblast-derived exosomes enhance macrophages to myofibroblasts transition and kidney fibrosis
by: Wenqiang Yu, et al.
Published: (2024-12-01) -
Autologous precision-cut lung slice co-culture models for studying macrophage-driven fibrosis
by: So-Yi Chang, et al.
Published: (2025-01-01) -
Iguratimod prevents renal fibrosis in unilateral ureteral obstruction model mice by suppressing M2 macrophage infiltration and macrophage–myofibroblast transition
by: Yueyuan Zhou, et al.
Published: (2024-12-01)